After an exiting start to 2019 with travels to India and the USA, more interesting events are approaching in the first half of this year:
We are looking forward to meeting many good scientists for inspiring discussions!
Our very successful symposia series comes to India in January 2019. Join us for this free one-day symposia in Bengaluru, Mumbai or New Delhi. We are looking forward to interesting talks and workshops highlighting new approaches and technologies being applied to the search for future therapeutics. For further details and registration please visit the symposium website for the respective city.
Our very successful symposia series comes to Frankfurt on 14 February 2019. Join us for this free one-day symposium highlighting new approaches and technologies being applied to the search for future therapeutics. For further details about the symposium please visit the symposium website.
Andrew Anighoro from Evotec will show us some examples from his work. Save your spot here.
Miss Charlotte von dem Knesebeck, German-based pupil in Bonn by the river Rhine was awarded the 1st Price in Chemistry by the Dr. Hans Riegel-Foundation for her work on the analysis of morphine binding modes in opioid receptors. Read the press release here.
With optimised algorithms and more chemistry knowledge included, the updated REAL Space Navigator gives ’search and find‘ access to an incredible 3.8 billion compounds ready for purchase. More information can be found in the press release.
BioSolveIT and Avergen win a prestigious PERMIDES grant from the European Union to fight against cancer exploiting protein-protein interaction inhibition.
Read the full press release here:
St. Augustin, Germany, May 17th 2016 –Â Today, weÂ announce a strategic partnership with Evotec AG ("Evotec") to create an immeasurably large molecular search space. The database, so-called 'EVOspace' will act as a gigantic "pool" of virtual molecules from which to mine novel, synthetically accessible molecularÂ entities for drug research.
Read the full press release here.
March 14, 2016 - Zealand and BioSolveIT create unique software tool, adding new dimensions to peptide drug design and development.
The full press release is here.
Optibrium announces next version with SeeSAR integration.
The next step in the outstanding collaboration between Optibrium and BioSolveIT is announced:
A new, seamless link between 2D and 3D structure-activity relationships guides more efficient
compound optimisation in StarDrop. The high speed and appealing 3D visualization plus analysis functions from SeeSAR, every chemist's SAR assistant, are now integrated in Optibrium's powerful ADME suite.
Read the full press release, and stay with us for more outcomes of our joint efforts.
BioSolveIT invites academic teams, non-profit organizations, and individuals to participate in an excitingÂ Scientific Challenge:
If you are working on a drug discovery problem, exploit the vastÂ breadth ofÂ BioSolveIT's software tools to meet your goals quicker and better.
More background can be found on a dedicated website:
Breaking News: BioSolveIT and Optibrium signed a collaboration agreement.Â The partnership will deliver a link between 2D and 3D design on medicinal chemists' desktops.
The synergies between ADME/Tox experts Optibrium and BioSolveIT will be of huge benefit for researchers in Medicinal Chemistry!
Read the full joint press release here.